SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Stock Idea & Analysis Community
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

10 pts

Opinion on  Myriad Genetics Inc (MYGN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Myriad Genetics ends development of Flurizan

Jun 30, 2008 12:01 PM UTC
11086577047d3f315cefde
Return Risk
+1.74% LOW
Sr. Analyst

http://biz.yahoo.com/ap/080630/myriad_genetics_flurizan.html?...

The whole program is gone.  The stock will be beaten over the next week or so when the market try to re-value the company's worth.

On the other hand, AAB-001(from ELN/WYE) has one less competitor worrying about!  There may also be a chance that ELN/WYE will go down with the news.  I will view this as an excellent opportunity to buy more eln shares in anticipation for the new at ICAD in July. 

MYGN:  This call was made on 06/30/08 @ $44.6
Rating:   Negative   $44.6 (06/30/08)
Closed:   07/26/2008 @ $64.0 (-43.50% in 26 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 Gerald Greene 17.79 +39.36% 76
2 krprasad 15.74 +15.90% 10
3 akiralegrand 14.31 +16.71% 41
4 stockmarketfunding.com 14.15 +22.86% 16
5 noshoes 13.66 +30.39% 183


POPULAR STOCKS
Symbol Company Name Sentiment
WM Washington Mutual Inc
GE General Electric Company
AAPL Apple Computer Inc
MO Altria Group Inc
PFE Pfizer Inc
WFC Wells Fargo & Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Myriad Genetics Inc (MYGN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by Nano Duck
Symbol SP Sentiment Rating Return Since
C Positive -54.46% 10/11/08
AIG Positive -51.04% 09/28/08
XLF Positive -40.08% 09/19/08
NNVC N/A Positive -6.98% 09/15/08
JEC Positive -39.35% 07/23/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch